NO20033803L - Karbamatforbindelser for anvendelse ved prevensjon eller terapi av bevegelseslidelser - Google Patents

Karbamatforbindelser for anvendelse ved prevensjon eller terapi av bevegelseslidelser

Info

Publication number: NO20033803L
Authority: NO; Norway
Prior art keywords: therapy; prevention; movement disorders; carbamate compounds; carbamate
Prior art date: 2001-02-27

Application number

NO20033803A

Other languages

English (en)

Norwegian (no)

Other versions

NO20033803D0 (no

Inventor

Carlos R Plata-Salaman

Boyu Zhao

Roy E Twyman

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-27

Filing date

2003-08-26

Publication date

2003-10-10

2003-08-26 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2003-08-26 Publication of NO20033803D0 publication Critical patent/NO20033803D0/no

2003-10-10 Publication of NO20033803L publication Critical patent/NO20033803L/no

Links

208000016285 Movement disease Diseases 0.000 title 1
150000004657 carbamic acid derivatives Chemical class 0.000 title 1
230000002265 prevention Effects 0.000 title 1
238000002560 therapeutic procedure Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Emergency Medicine (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20033803A 2001-02-27 2003-08-26 Karbamatforbindelser for anvendelse ved prevensjon eller terapi av bevegelseslidelser NO20033803L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US27168301P	2001-02-27	2001-02-27
PCT/US2002/005542 WO2002067926A1 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating movement disorders
US10/081,501 US6589985B2 (en)	2001-02-27	2002-02-21	Carbamate compounds for use in preventing or treating movement disorders

Publications (2)

Publication Number	Publication Date
NO20033803D0 NO20033803D0 (no)	2003-08-26
NO20033803L true NO20033803L (no)	2003-10-10

Family

ID=26765643

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20033803A NO20033803L (no)	2001-02-27	2003-08-26	Karbamatforbindelser for anvendelse ved prevensjon eller terapi av bevegelseslidelser

Country Status (27)

Country	Link
US (1)	US6589985B2 (cs)
EP (1)	EP1411917B1 (cs)
JP (1)	JP2004527492A (cs)
KR (1)	KR100858232B1 (cs)
CN (1)	CN1262272C (cs)
AR (1)	AR033426A1 (cs)
AT (1)	ATE369130T1 (cs)
AU (1)	AU2002247204B2 (cs)
BR (1)	BR0207831A (cs)
CA (1)	CA2439478C (cs)
CY (1)	CY1106924T1 (cs)
CZ (1)	CZ20032299A3 (cs)
DE (1)	DE60221670T2 (cs)
DK (1)	DK1411917T3 (cs)
ES (1)	ES2291454T3 (cs)
HU (1)	HUP0303344A3 (cs)
IL (2)	IL157592A0 (cs)
MX (1)	MXPA03007719A (cs)
MY (1)	MY157373A (cs)
NO (1)	NO20033803L (cs)
NZ (1)	NZ551954A (cs)
PL (1)	PL364679A1 (cs)
PT (1)	PT1411917E (cs)
RS (1)	RS50676B (cs)
RU (1)	RU2294739C2 (cs)
TW (1)	TWI331524B (cs)
WO (1)	WO2002067926A1 (cs)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002007822A2 (en) *	2000-07-21	2002-01-31	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
IL157591A0 (en) *	2001-02-27	2004-03-28	Ortho Mcneil Pharm Inc	Carbamate compounds for use in preventing or treating neurodegenerative disorders
PL368164A1 (en)	2001-07-16	2005-03-21	Ortho-Mcneil Pharmaceutical, Inc.	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
AU2006254899B2 (en) *	2005-06-08	2011-11-24	Sk Biopharmaceuticals Co., Ltd.	Treatment of sleep-wake disorders
PE20070325A1 (es) *	2005-06-29	2007-05-12	Alza Corp	Formas de dosificacion oral que comprenden compuestos derivados de carbamato
CA2616721C (en) *	2005-07-26	2014-01-21	Janssen Pharmaceutica N.V.	Methods for treating substance-related disorders
CA2667909A1 (en) *	2006-10-31	2008-05-08	Janssen Pharmaceutica N.V.	Treatment of pervasive developmental disorders
WO2011055944A2 (en)	2009-11-06	2011-05-12	Sk Holdings Co., Ltd.	Methods for treating fibromyalgia syndrome
KR101783632B1 (ko)	2009-11-06	2017-10-10	에스케이바이오팜 주식회사	주의력 결핍/과잉행동 장애(ａｄｈｄ)의 치료 방법
US9610274B2 (en)	2010-06-30	2017-04-04	Sk Biopharmaceuticals Co., Ltd.	Methods for treating bipolar disorder
US8623913B2 (en) *	2010-06-30	2014-01-07	Sk Biopharmaceuticals Co., Ltd.	Methods for treating restless legs syndrome
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN109939092B (zh)	2013-03-12	2022-03-22	比皮艾思药物研发有限公司	用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
JP6131341B2 (ja)	2013-03-12	2017-05-17	バイオ−ファームソリューションズカンパニーリミテッド	フェニルカルバメート化合物及びこれを含む精神疾患の予防又は治療用組成物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄａｎｄａｃｏｍｐｏｓｉｔｉｏｎｆｏｒｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇａｐｓｙｃｈｉａｔｒｉｃｄｉｓｏｒｄｅｒｃｏｍｐｒｉｓｉｎｇｔｈｅｓａｍｅ｝
US10351519B2 (en) *	2016-02-29	2019-07-16	Bio-Pharm Solutions Co., Ltd.	Sulfamate derivative compounds, processes for preparing them and their uses
US10195151B2 (en)	2016-09-06	2019-02-05	Jazz Pharmaceuticals International Iii Limited	Formulations of (R)-2-amino-3-phenylpropyl carbamate
US11033531B2 (en) *	2016-12-14	2021-06-15	Sk Biopharmaceuticals Co., Ltd.	Use of carbamate compound for preventing, alleviating, or treating tremors or tremor syndrome
EP3630072A4 (en)	2017-06-02	2021-03-10	Jazz Pharmaceuticals Ireland Limited	METHODS AND COMPOSITIONS FOR TREATMENT OF EXCESSIVE Drowsiness
US10940133B1 (en)	2020-03-19	2021-03-09	Jazz Pharmaceuticals Ireland Limited	Methods of providing solriamfetol therapy to subjects with impaired renal function
CA3191072A1 (en) *	2020-08-31	2022-03-03	Bio-Pharm Solutions Co., Ltd.	Phenyl alkyl carbamate compounds for use in preventing or treating neurodegenerative disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3313692A (en)	1958-04-21	1967-04-11	Armour Pharma	Method of inducing calming and muscle relaxation with carbamates
US3265728A (en)	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol

2002
- 2002-02-21 DE DE60221670T patent/DE60221670T2/de not_active Expired - Lifetime
- 2002-02-21 NZ NZ551954A patent/NZ551954A/en unknown
- 2002-02-21 EP EP02714978A patent/EP1411917B1/en not_active Expired - Lifetime
- 2002-02-21 WO PCT/US2002/005542 patent/WO2002067926A1/en not_active Ceased
- 2002-02-21 HU HU0303344A patent/HUP0303344A3/hu unknown
- 2002-02-21 PL PL02364679A patent/PL364679A1/xx not_active Application Discontinuation
- 2002-02-21 PT PT02714978T patent/PT1411917E/pt unknown
- 2002-02-21 US US10/081,501 patent/US6589985B2/en not_active Expired - Fee Related
- 2002-02-21 CA CA2439478A patent/CA2439478C/en not_active Expired - Fee Related
- 2002-02-21 ES ES02714978T patent/ES2291454T3/es not_active Expired - Lifetime
- 2002-02-21 RU RU2003128985/14A patent/RU2294739C2/ru not_active IP Right Cessation
- 2002-02-21 AU AU2002247204A patent/AU2002247204B2/en not_active Ceased
- 2002-02-21 DK DK02714978T patent/DK1411917T3/da active
- 2002-02-21 CN CNB028089243A patent/CN1262272C/zh not_active Expired - Fee Related
- 2002-02-21 IL IL15759202A patent/IL157592A0/xx unknown
- 2002-02-21 CZ CZ20032299A patent/CZ20032299A3/cs unknown
- 2002-02-21 MX MXPA03007719A patent/MXPA03007719A/es active IP Right Grant
- 2002-02-21 AT AT02714978T patent/ATE369130T1/de active
- 2002-02-21 RS YUP-677/03A patent/RS50676B/sr unknown
- 2002-02-21 JP JP2002567293A patent/JP2004527492A/ja active Pending
- 2002-02-21 BR BR0207831-7A patent/BR0207831A/pt not_active Application Discontinuation
- 2002-02-21 KR KR1020037011271A patent/KR100858232B1/ko not_active Expired - Fee Related
- 2002-02-27 TW TW091103503A patent/TWI331524B/zh not_active IP Right Cessation
- 2002-02-27 MY MYPI20020692A patent/MY157373A/en unknown
- 2002-02-27 AR ARP020100698A patent/AR033426A1/es unknown
2003
- 2003-08-26 IL IL157592A patent/IL157592A/en not_active IP Right Cessation
- 2003-08-26 NO NO20033803A patent/NO20033803L/no not_active Application Discontinuation
2007
- 2007-10-10 CY CY20071101301T patent/CY1106924T1/el unknown

Also Published As

Publication number	Publication date
CA2439478A1 (en)	2002-09-06
MXPA03007719A (es)	2004-11-12
CN1505508A (zh)	2004-06-16
DE60221670T2 (de)	2008-04-30
MY157373A (en)	2016-06-15
KR100858232B1 (ko)	2008-09-12
WO2002067926A1 (en)	2002-09-06
BR0207831A (pt)	2004-06-22
TWI331524B (en)	2010-10-11
NO20033803D0 (no)	2003-08-26
HK1067305A1 (en)	2005-04-08
AR033426A1 (es)	2003-12-17
AU2002247204B2 (en)	2006-08-24
PL364679A1 (en)	2004-12-13
HUP0303344A2 (hu)	2004-01-28
US20020151585A1 (en)	2002-10-17
RU2294739C2 (ru)	2007-03-10
CN1262272C (zh)	2006-07-05
CA2439478C (en)	2010-05-18
RU2003128985A (ru)	2005-03-10
US6589985B2 (en)	2003-07-08
IL157592A (en)	2009-12-24
JP2004527492A (ja)	2004-09-09
CZ20032299A3 (cs)	2004-08-18
PT1411917E (pt)	2007-09-17
KR20030074847A (ko)	2003-09-19
YU67703A (sh)	2006-08-17
CY1106924T1 (el)	2012-09-26
RS50676B (sr)	2010-06-30
DK1411917T3 (da)	2007-09-24
IL157592A0 (en)	2004-03-28
EP1411917A1 (en)	2004-04-28
NZ551954A (en)	2008-07-31
DE60221670D1 (de)	2007-09-20
ES2291454T3 (es)	2008-03-01
EP1411917B1 (en)	2007-08-08
ATE369130T1 (de)	2007-08-15
HUP0303344A3 (en)	2012-07-30

Legal Events

Date	Code	Title	Description
2012-10-01	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20033798L (no)	2003-09-26	Karbamatforbindelser for bruk ved prevensjon eller terapi av neurodegenerative lidelser
NO20035522D0 (no)	2003-12-11	Kinuklidin-substituerte multisykliske heteroaryler for behandling av sykdom
DK1427437T3 (da)	2013-03-04	Oxyntomodulin til forebyggelse eller behandling af overvægt
DK1446122T3 (da)	2006-07-03	Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften
DK1411917T3 (da)	2007-09-24	Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bevægelsesforstyrrelser
IS7099A (is)	2004-01-08	Efnasambönd til að meðhöndla bólgutruflanir
BR0214263B1 (pt)	2013-04-02	processos para a preparaÇço de uma composiÇço para o tratamento dos cabelos.
HUP0401514A3 (en)	2012-08-28	Pharmaceutical compositions for the treatment of asthma
CY2014019I2 (el)	2015-12-09	Παραγωγα φαιναιθανολαμινης για θεραπεια ασθενειων του αναπνευστικου
ES2414872T8 (es)	2014-11-06	Terapia combinada para la prevención o tratamiento de la enfermedad de Alzheimer y kit correspondiente
NO20033594L (no)	2003-10-02	Fenetanolamin-derivater for behandling av luftveissykdommer
ZA200309627B (en)	2005-08-31	Compounds for the treatment of metabolic disorders
NO20042680L (no)	2004-06-25	Fremgangsmater for fremstilling av O-demetylvenflaxine
PT1392292E (pt)	2006-05-31	Piranoindazoles e sua utilizacao para o tratamento de glaucoma
NO20041386L (no)	2004-05-11	Kombinasjoner for bahandling av immunoinflammatoriske forstyrrelser
NO20040253L (no)	2004-03-19	Fremgangsmater for behandling av leverfibroser
NO20033443L (no)	2003-09-30	Anvendelse av CD-2-bindende midler ved behandling eller forebygging av hudlidelser
PT1321135E (pt)	2006-09-29	Composicao para o tigimento de oxidacao das fibras ceratinicas
NO20033801D0 (no)	2003-08-26	Karbamatforbindelser for anvendelse ved forebygging eller behandling av psykotiske forstyrrelser
NO20033804L (no)	2003-09-30	Karbamatforbindelser for behandling av smerte
NO20054913D0 (no)	2005-10-24	Anvendelse av clustein for behandling og/eller forebyggelse av perifere nevrologiske lidelser
PL375564A1 (en)	2005-11-28	Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma
PT1268482E (pt)	2004-01-30	Piranoindois para o tratamento de glaucoma
PT1225890E (pt)	2005-05-31	Rivastigmina para o tratamento de doencas oculares
NO20012612D0 (no)	2001-05-28	Isonipecotamider for behandling av integren-formidlede lidelser